Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Janssen-Cilag submits MAA to EMA for darunavir-based single tablet regimen

Sep. 13, 2016

New York Blood Center patents anti-HIV antibody-drug conjugates

Sep. 8, 2016

European Commission grants marketing authorization to Gilead's Truvada

Aug. 23, 2016

Viiv Healthcare starts phase III trial for two-drug regimen of dolutegravir/lamivudine

Aug. 18, 2016

Genmab and Gilead Sciences enter DuoBody license agreement

Aug. 11, 2016

ANXA1 signaling as a novel therapeutic target for the resolution of immune dysfunction in HIV

Aug. 11, 2016

NIH awards a new contract to the IAVI to advance AIDS vaccine development

Aug. 10, 2016

GeoVax awarded contract from NIH to further develop HIV vaccine

Aug. 3, 2016

Janssen files for approval of darunavir/cobicistat combination tablets in Japan

July 29, 2016

Novel bispecific immunoadhesin shows promise for HIV prevention and immunotherapy

July 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...